April 29, 2021

Rituximab and B-Cell Therapy Can Delay Lyme Disease Diagnosis B-cell suppressive therapies such as rituximab can delay Lyme disease diagnosis. These medications reduce the body’s ability to produce antibodies — the same antibodies that standard Lyme disease tests rely on to detect infection. As a result, patients receiving immune-modulating therapy may have false-negative or borderline